Malignant Pancreatic Neoplasm — Trials

Malignant Pancreatic Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,630 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 904
Recruiting: 503
Ph III recruiting: 45
Growth YoY: +18.8%
Industry share: 32%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.5%
Trials / 1,000 deaths: 18.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (516)

clinicaltrialsPublishedShowing 301–350 of 1,346 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07145255	Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors	recruiting	Phase 1 / Phase 2	150	MBrace TherapeuticsINDUSTRY	1	Feb 17, 2026	clinicaltrials
NCT07415525	IBI343 Combined With Chemotherapy as Neoadjuvant Therapy in Borderline Resectable Pancreatic Cancer	not yet recruiting	Phase 2	40	Zhejiang UniversityOTHER	1	Feb 17, 2026	clinicaltrials